CTLA4 and cancer: Cohen et al. observed 62 patients with advanced cancer receiving ICIs treatment and found that psychological issues can affect treatment outcomes through pro-inflammatory cytokines and Soluble cytotoxic T-lymphocyte-associated antigen 4 (sCTLA-4) (Cohen et al., 2023).